Dravet syndrome Pharmacotherapy Consultation S: Per mother: “My child currently weight 42 lbs, we tried the keto diet in winter – spring ’06 with no change in seizure control. The seizures he has been having recently are a combination of eye fluttering, chin tucking in to chest, drooling, with occasional myoclonics. He displays this activity for […]
ICE Alliance – Have Hope for Intractable Epilepsies in Children Together we will Improve the Outcome and Reach for the Cure. Epilepsy is a condition where recurrent electrical discharges in the brain disturb the normal functioning of the nervous system. These episodes of disturbance are called seizures. Two or more unprovoked (caused by fever or […]
Alternative therapies in treating epilepsy Yatin Patel Doctor of Pharmacy Candidate Wingate University School of Pharmacy Michelle Welborn, PharmD Preceptor Intractable Childhood Epilepsy Alliance www.epilepsytreatmentdrugs.com
Approximately 5,000 rare diseases have been identified. 10-20 million Americans suffer from rare diseases, 50% of which are pediatric patients. A disease is considered rare or ‘orphan’ when the prevalence in the United States is less than 200,000. The diesease is termped ‘orphan’ because the pharmaceutical industry historically has not had an interest in developing […]
To all ICE advocates: This letter was written by a parent of a child with Dravet syndrome who appealed to the Ohio state Medicaid department for nursing services to care for her child. Each state has a different policy and plan for developmentally disabled children and their care, dependent on level of need. Please look […]
Dear Parent: This is the template I have given to many parents who have advocated for payment of stiripentol, clobazam or Epistatus by private insurance or Medicaid. My first job out of residency was as Clinical Formulary Manager for a Health Maintenance Organization (HMO). In this role, I decided if exceptions should be made for […]
Dravet syndrome Harriet Davies, PharmD written for: National Organization for Rare Diseases March 2009 Synonyms of Dravet syndrome Severe Myoclonic Epilepsy in Infancy (SMEI) Polymorphic Epilepsy in Infancy (PMEI) Epilepsy with polymorphic seizures
Improving Outcomes in Pediatric Epilepsy Syndromes Stop the Status Improving OUtcomes in Pediatric Epilepsy Syndromes Overview – Seizures and Epilepsy Syndromes – Seizure Emergencies – Febrile Seizures
ICE Alliance’s Professional Advisory Board is a group of leading intractable childhood epilepsy, genetics, and drug development researchers from both academia and industry, clinicians who work with patients with intractable epilepsy, and experts from related fields. These members live all over the world and review grant proposals, and attend relevant meetings to help determine which […]
The Piracetam-nootropics (pyrrolidone derivatives) have been exhaustively researched for more than three decades. Experimental and clinical work first focused on their so-called nootropic effects; later came the possibilities for neuroprotection after stroke and use as antiepileptic agents. The concept and definition of a “nootropic drug” was first proposed in 1972 by C.E. Guirgea, the principal Piracetam researcher for UCB Pharmaceutical Company of Belgium that launched Piracetam. He coined the term”nootropic” from the italic words “noos” (mind) and “tropein” (to turn toward), to mean enhancement of learning and memory.
Click the link above to download the full article in a new browser window or new tab.